KOCAA
Knights of Columbus Asset Advisors Portfolio holdings
AUM
$1.65B
This Quarter Return
+13.8%
1 Year Return
+26.62%
3 Year Return
+114.99%
5 Year Return
+224.68%
10 Year Return
–
AUM
$1.55B
AUM Growth
+$1.55B
(+42%)
Cap. Flow
+$336M
Cap. Flow
% of AUM
21.62%
Top 10 Holdings %
Top 10 Hldgs %
17.69%
Holding
397
New
22
Increased
246
Reduced
60
Closed
24
Top Buys
| 1 |
Synovus
SNV
|
$10.8M |
| 2 |
Constellium
CSTM
|
$8.82M |
| 3 |
Matador Resources
MTDR
|
$8.34M |
| 4 |
Brink's
BCO
|
$7.76M |
| 5 |
Maximus
MMS
|
$7.7M |
Top Sells
| 1 |
Quanta Services
PWR
|
$5.26M |
| 2 |
Motorola Solutions
MSI
|
$3.95M |
| 3 |
PepsiCo
PEP
|
$3.92M |
| 4 |
KBR
KBR
|
$3.85M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$3.26M |
Sector Composition
| 1 | Technology | 22.82% |
| 2 | Financials | 16.29% |
| 3 | Industrials | 11.88% |
| 4 | Healthcare | 11.28% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
iShares Global Tech ETF
IXN
$5.71B
| $157K | 0.01% |
2,307
| – | – |
|
327
UBS Group
UBS
$128B
| $155K | 0.01% |
+5,020
| New | +$155K |
|
328
The Ensign Group
ENSG
$9.91B
| $152K | 0.01% |
1,353
+106
| +9% | +$11.9K |
|
329
NetEase
NTES
$86.2B
| $150K | 0.01% |
1,605
| – | – |
|
330
Shell
SHEL
$215B
| $149K | 0.01% |
2,265
+645
| +40% | +$42.4K |
|
331
Bally's
BALY
$489M
| $146K | 0.01% |
10,482
-8,459
| -45% | -$118K |
|
332
Heron Therapeutics
HRTX
$207M
| $142K | 0.01% |
83,482
+41,741
| +100% | +$71K |
|
333
Campbell Soup
CPB
$9.52B
| $136K | 0.01% |
3,138
+68
| +2% | +$2.94K |
|
334
General Mills
GIS
$26.4B
| $135K | 0.01% |
2,079
+44
| +2% | +$2.87K |
|
335
Invesco DB US Dollar Index Bullish Fund
UUP
$174M
| $133K | 0.01% |
4,922
-807
| -14% | -$21.9K |
|
336
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $129K | 0.01% |
3,137
+313
| +11% | +$12.9K |
|
337
Baidu
BIDU
$32.8B
| $126K | 0.01% |
1,057
| – | – |
|
338
iShares Ultra Short Duration Bond Active ETF
ICSH
$6.2B
| $125K | 0.01% |
2,475
| – | – |
|
339
Fate Therapeutics
FATE
$120M
| $120K | 0.01% |
32,184
+16,092
| +100% | +$60.2K |
|
340
Boyd Gaming
BYD
$6.88B
| $118K | 0.01% |
1,882
+509
| +37% | +$31.9K |
|
341
Natera
NTRA
$23.1B
| $116K | 0.01% |
1,853
-116
| -6% | -$7.27K |
|
342
Nutrien
NTR
$28B
| $113K | 0.01% |
2,005
+44
| +2% | +$2.48K |
|
343
Alibaba
BABA
$322B
| $112K | 0.01% |
1,440
-475
| -25% | -$36.8K |
|
344
Invesco DB Precious Metals Fund
DBP
$199M
| $111K | 0.01% |
2,230
+45
| +2% | +$2.25K |
|
345
Chemours
CC
$2.31B
| $108K | 0.01% |
3,429
+74
| +2% | +$2.33K |
|
346
Invesco DB Agriculture Fund
DBA
$822M
| $105K | 0.01% |
5,075
-155
| -3% | -$3.22K |
|
347
Vanguard Real Estate ETF
VNQ
$34.6B
| $91.9K | 0.01% |
1,040
+169
| +19% | +$14.9K |
|
348
Franklin FTSE India ETF
FLIN
$2.28B
| $91K | 0.01% |
+2,610
| New | +$91K |
|
349
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
$2.87B
| $90.7K | 0.01% |
3,662
| – | – |
|
350
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.3B
| $87.5K | 0.01% |
3,657
| – | – |
|